VYNE Therapeutics Inc (VYNE)

[jugs]

The reverse split has been approved by a huge majority, in my opinion---with 89% of votes cast in favor of the reverse.

I didn't approve of it as I know from experience that this stock will likely suffer the throes of many biotechs enacting such measures.

Translation:

The now adopted reverse could turn into a 25% share price drop quick as a wink.

I'm not buying into the thesis that less (fewer shares) is better. And even if the accepted ratio should become 1:7 dependent upon BOD determination, we're still looking at a $12 share. And my expectation is that we'll be seeing shares falling back to $7. The pandemic has to be greatly affecting earnings to the downside, I'm positive.

If I can get $1.80/share in the next few days, I'll be selling some in the expectation that I'll be in position to replace sold shares at a much lower price point. I'm leaning towards selling about a third of my position. $1.80 is my cost basis.

My hope is that others here will come to terms with their own situations and weigh things important to them. I don't make decisions for others. Anything I say on this board is not more than my own opinion. As such, it shouldn't be valued as equal to that of any other board contributor.

So, then, can we hear from other investors here? I'd like that for sure.